Cargando…
New and emerging combination therapies for esophageal cancer
Esophageal cancer comprises two different histological forms – squamous cell carcinoma (SCC) and adenocarcinoma (AC). While the incidence of AC has increased steeply in Western countries during the last few years, the incidence of SCC is fairly stable. Both forms differ in pathogenesis and response...
Autores principales: | Wiedmann, Marcus W, Mössner, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706320/ https://www.ncbi.nlm.nih.gov/pubmed/23869177 http://dx.doi.org/10.2147/CMAR.S32199 |
Ejemplares similares
-
Safety and Efficacy of Sunitinib in Patients with Unresectable Pancreatic Neuroendocrine Tumors
por: Wiedmann, Marcus W., et al.
Publicado: (2012) -
Advances in targeted therapies and new promising targets in esophageal cancer
por: Belkhiri, Abbes, et al.
Publicado: (2015) -
Immune-based combination therapy for esophageal cancer
por: Wang, Huiling, et al.
Publicado: (2022) -
Photodynamic Therapy for Esophageal Cancer
por: Inoue, Takahiro, et al.
Publicado: (2021) -
Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics
por: Škubník, Jan, et al.
Publicado: (2021)